Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bauer

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Elife|July 29, 2021
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strainsNikhil Faulkner, Kevin W Ng, Mary Y Wu, et al.
Journal of Hepatology|December 6, 2021
HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver diseaseGeorg Semmler, Elias Laurin Meyer, Karin Kozbial, et al.
BMJ Neurology Open|December 22, 2025
Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosisMarianne J Shawe-Taylor, David Greenwood, Anna He, et al.
Journal of Medicinal Chemistry|April 23, 2008
Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinaseBrian K Albrecht, Jean-Christophe Harmange, David Bauer, et al.
Journal of Medicinal Chemistry|March 8, 2008
Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitorsMatthew M Weiss, Jean-Christophe Harmange, Anthony J Polverino, et al.
Wiener Klinische Wochenschrift|September 29, 2023
ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in AustriaCaroline Schwarz, David Bauer, Livia Dorn, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 22, 2025
Outcomes of complex, high-risk percutaneous coronary intervention in patients with severe aortic stenosis: the ASCoP registryClaudio Montalto, Andrea R Munafò, Francesco Soriano, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) InhibitorsRyan P Wurz, Liping H Pettus, Kate Ashton, et al.
New Biotechnology|October 31, 2015
New technologies for DNA analysis--a review of the READNA ProjectSteven McGinn, David Bauer, Thomas Brefort, et al.
Annals of Neurology|December 23, 2011
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility lociNikolaos A Patsopoulos, , , et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Elife|July 29, 2021
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strainsNikhil Faulkner, Kevin W Ng, Mary Y Wu, et al.
Journal of Hepatology|December 6, 2021
HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver diseaseGeorg Semmler, Elias Laurin Meyer, Karin Kozbial, et al.
BMJ Neurology Open|December 22, 2025
Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosisMarianne J Shawe-Taylor, David Greenwood, Anna He, et al.
Journal of Medicinal Chemistry|April 23, 2008
Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinaseBrian K Albrecht, Jean-Christophe Harmange, David Bauer, et al.
Journal of Medicinal Chemistry|March 8, 2008
Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitorsMatthew M Weiss, Jean-Christophe Harmange, Anthony J Polverino, et al.
Wiener Klinische Wochenschrift|September 29, 2023
ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in AustriaCaroline Schwarz, David Bauer, Livia Dorn, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 22, 2025
Outcomes of complex, high-risk percutaneous coronary intervention in patients with severe aortic stenosis: the ASCoP registryClaudio Montalto, Andrea R Munafò, Francesco Soriano, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) InhibitorsRyan P Wurz, Liping H Pettus, Kate Ashton, et al.
New Biotechnology|October 31, 2015
New technologies for DNA analysis--a review of the READNA ProjectSteven McGinn, David Bauer, Thomas Brefort, et al.
Annals of Neurology|December 23, 2011
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility lociNikolaos A Patsopoulos, , , et al.
Pageof 18